News

- 13TH JANUARY 2023
Company led medicines recall: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection Mawdsley-Brooks & Company Limited
CLMR number: CLMR (23)A/01 Date issued: 12th January 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a company-led medicines recall for: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection (Mawdsley-Brooks & Company Limited). Fluphenazin-neuraxpharm® D 100 mg/ml Solution for Injection [unlicensed medicine] Batch number Expiry Date Pack Size First Distributed 200686
Read more
- PSNC News
- 11TH JANUARY 2023
Pharmacy Vision: PSNC to hold engagement events
Work to develop a new vision and strategic options for community pharmacy is now well underway, being led by Nuffield Trust and The King’s Fund. An online consultation to gather views from the sector closed last month with the submissions now being collated prior to being passed to Nuffield Trust and The King’s Fund. Engagement
Read more
- PSNC News
- 11TH JANUARY 2023
Joint letter calls for workforce plan to include whole of pharmacy
PSNC and other pharmacy leaders have warned the Government about a lack of engagement with stakeholders around the development of its long-term workforce plan. A joint letter signed by representatives from 14 pharmacy organisations has called for reassurance that the workforce plan, expected by April 2023, will cover the entirety of the pharmacy workforce across
Read more
- PSNC News
- 10TH JANUARY 2023
Free PPE for pharmacy teams extended until March 2024
The Government’s scheme providing free personal protective equipment (PPE) to health and care providers, including community pharmacies in England, has been extended for another year. The Department of Health and Social Care (DHSC) has announced that it will continue to supply all categories of PPE, free of charge, for frontline health and social care staff
Read more
- PSNC News
- 9TH JANUARY 2023
PQS: Declaration questions published
The NHS Business Services Authority (NHSBSA) has published the questions which will be included in the 2022/23 Pharmacy Quality Scheme (PQS) declaration so community pharmacy contractors can view these ahead of making their declaration. The questions are available on the NHSBSA PQS hub page; contractors should scroll down to the ‘Declaration questions’ section where they can
Read more
- PSNC News

- 3RD JANUARY 2023
MHRA Class 4 Medicines Defect Information: Bylvay 1200 micrograms Hard Capsules (Albireo AB)
Class 4 Medicines Defect Information: Bylvay 1200 micrograms Hard Capsules (Albireo AB) Drug alert number: EL (23)A/01 Date issued: 3 January 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Bylvay 1200 micrograms Hard Capsules, PLGB 36216/0004 Batch number Expiry date Pack size First distributed
Read more
- PSNC News
- 3RD JANUARY 2023
Medicine Supply Notification: Norditropin (somatropin) Flexpro® 10mg/1.5ml and Norditropin (somatropin) NordiFlex® 5mg/1.5ml, 10mg/1.5ml and 15mg/1.5ml solution for injection pre-filled pens
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Norditropin (somatropin) Flexpro® 10mg/1.5ml and Norditropin (somatropin) NordiFlex® 5mg/1.5ml, 10mg/1.5ml and 15mg/1.5ml solution for injection pre-filled pens. MSN/2023/001 Tier 2 – medium impact Date of issue 3rd January 2023 Norditropin (somatropin) Flexpro® 10mg pen is out of stock until early February
Read more
- PSNC News
- 3RD JANUARY 2023
Medicine Supply Notification: Prochlorperazine (Stemetil®) 12.5mg/ml solution for injection ampoules
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Prochlorperazine (Stemetil®) 12.5mg/ml solution for injection ampoules. MSN/2022/113 Tier 2 – medium impact Date of issue 23rd December 2022 Prochlorperazine (Stemetil®) 12.5mg/ml solution for injection ampoules are out of stock until w/c 16th January 2023. Limited supplies remain available in NHS
Read more
- PSNC News
- 3RD JANUARY 2023
Medicine Supply Notification: Selegiline (Eldepryl® ) 5mg and 10mg tablets
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Selegiline (Eldepryl®) 5mg and 10mg tablets. MSN/2022/112 Tier 2 – medium impact Date of issue 23rd December 2022 Selegiline (Eldepryl®) 5mg and 10mg tablets are out of stock until April 2023. Rasagiline 1mg tablets remain available and can support a full
Read more
- PSNC News
- 3RD JANUARY 2023
Mandatory weight management campaign starts today
The national weight management health campaign commences from today (Tuesday 3rd January) and will run until Sunday 29th January 2023. NHS England and PSNC agreed that contractors will only have to participate in one mandatory national health campaign for 2022/23 (pharmacies can be required to participate in up to six health campaigns at the request
Read more
- PSNC News

Company led medicines recall: Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection Mawdsley-Brooks & Company Limited

Pharmacy Vision: PSNC to hold engagement events

Joint letter calls for workforce plan to include whole of pharmacy

Free PPE for pharmacy teams extended until March 2024

PQS: Declaration questions published

MHRA Class 4 Medicines Defect Information: Bylvay 1200 micrograms Hard Capsules (Albireo AB)

Medicine Supply Notification: Norditropin (somatropin) Flexpro® 10mg/1.5ml and Norditropin (somatropin) NordiFlex® 5mg/1.5ml, 10mg/1.5ml and 15mg/1.5ml solution for injection pre-filled pens

Medicine Supply Notification: Prochlorperazine (Stemetil®) 12.5mg/ml solution for injection ampoules

Medicine Supply Notification: Selegiline (Eldepryl® ) 5mg and 10mg tablets

Mandatory weight management campaign starts today

OUR OFFICE

CONTACT US

MESSAGE US

Contact Us

Quick Links

Our LPCs